A probiotic that prevents obesity could be on the horizon.
Bacteria that produce a therapeutic compound in the gut inhibit weight gain, insulin resistance and other adverse effects of a high-fat diet in mice, Vanderbilt University investigators have discovered.
“Of course it’s hard to speculate from mouse to human,” said senior investigator Sean Davies, Ph.D., assistant professor of Pharmacology. “But essentially, we’ve prevented most of the negative consequences of obesity in mice, even though they’re eating a high-fat diet.”
Regulatory issues must be addressed before moving to human studies, Davies said, but the findings published in the August issue of the Journal of Clinical Investigation suggest that it may be possible to manipulate the bacterial residents of the gut – the gut microbiota — to treat obesity and other chronic diseases.
Read more . . .
The Latest on: Obesity
[google_news title=”” keyword=”Obesity” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Obesity
- Why does working a night shift raise the risk for diabetes and obesity? Experts weigh inon May 9, 2024 at 2:29 pm
Working a night shift for even a short time could negatively impact your health and scientists are researching why.
- Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundupon May 9, 2024 at 2:11 pm
Health-care companies rose as optimism about a boom in obesity drugs regained momentum. Novo Nordisk shares ticked up after the maker of obesity ...
- Study shows how night shift work can raise risk of diabetes, obesityon May 9, 2024 at 12:55 pm
Just a few days on a night shift schedule throws off protein rhythms related to blood glucose regulation, energy metabolism and inflammation, processes that can influence the development of chronic ...
- Gut bacteria identified as potential link between maternal smoking and child obesityon May 9, 2024 at 12:44 pm
It's long been established that babies born to mothers who smoked are more likely to be obese. However, researchers at the University of Alberta believe they're closer to understanding why that ...
- Novo Nordisk, Flagship to develop next-generation obesity drugson May 9, 2024 at 10:22 am
Flagship Pioneering’s Metaphore unit has announced a new collaboration with Novo Nordisk (NVO) for the development of next-generation obesity management drugs. Read more here.
- How we can bridge the obesity-care gap for Black Americanson May 9, 2024 at 6:23 am
OPINION: It is time to advocate for legislative changes that will ensure every individual has access to life-saving medical treatments for obesity. The post How we can bridge the obesity-care gap for ...
- Novo Nordisk ties up with Metaphore to develop new obesity drugson May 9, 2024 at 5:55 am
Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs.
- Opinion: A year on Ozempic taught me we’re thinking about obesity all wrongon May 8, 2024 at 10:01 pm
This is happening because we are trapped in a set of old stories about what obesity is and the morally acceptable ways to overcome it. But the fact that so many of us are turning to the new ...
- Healthy eating, robust activity can combat growing problem of childhood obesity (copy)on May 8, 2024 at 5:00 pm
Among 12-19-year-olds, the rate tops 22%. One of every five children age 2-19 is obese. There’s no doubt that obesity is a serious problem among children and adolescents. Some local experts addressed ...
- Continuous Glucose Monitors Gain Favor in Obesityon May 7, 2024 at 6:45 am
The off-label use of CGMs for people possibly on the verge of, but not yet diagnosed with, diabetes is seen as a potential tool to help reverse course; over-the-counter version highly anticipated.
via Bing News
